Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Organ preservation.

Mark Hicks1, Alfred Hing, Ling Gao

  • 1Heart and Lung Transplant Unit and Department of Clinical Pharmacology, St. Vincent's Hospital, Sydney, Australia.

Methods in Molecular Biology (Clifton, N.J.)
|June 23, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cellular heterogeneity of pluripotent stem cell-derived cardiomyocyte grafts is mechanistically linked to treatable arrhythmias.

Nature cardiovascular research·2024
Same author

Case report: Management of infiltrative basosquamous carcinoma of the sternum.

International journal of surgery case reports·2023
Same author

Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model.

Journal of visualized experiments : JoVE·2023
Same author

Characterisation of Rare Left Partial Anomalous Pulmonary Venous Connection.

Heart, lung & circulation·2020
Same author

Ventricular Tachycardia Storm Ablation With Pre-Emptive Circulatory Support by Extracorporeal Membrane Oxygenation: Australian Experience.

Heart, lung & circulation·2020
Same author

Ventricular Tachycardia in a Patient With Dilated Cardiomyopathy Caused by a Novel Mutation of Lamin A/C Gene: Insights From Features on Electroanatomic Mapping, Catheter Ablation and Tissue Pathology.

Heart, lung & circulation·2020

Donor organ quality significantly impacts transplant success. Strategies to mitigate brain death and ischemia/reperfusion injury are crucial, especially with increasing reliance on marginal donors for heart and lung transplants.

Area of Science:

  • Transplantation immunology
  • Organ preservation
  • Surgical outcomes

Background:

  • Organ transplant success hinges on donor organ quality.
  • Cadaveric organ transplant outcomes are inferior to living donor transplants.
  • Brain death and transplantation induce organ dysfunction via hemodynamic, neurohormonal, and inflammatory changes.

Purpose of the Study:

  • To discuss strategies minimizing adverse effects of brain death and ischemia/reperfusion injury in donor hearts and lungs.
  • To address the growing demand for organ transplantation and the increasing use of marginal donors.

Main Methods:

  • Review of factors affecting donor organ quality, including donor age, disease, brain death, management, storage, and reperfusion.
  • Analysis of data on ischemic time and its impact on primary graft failure and mortality for heart and lung transplants.

Related Experiment Videos

  • Discussion of strategies to mitigate negative consequences of brain death and ischemia/reperfusion injury.

    • Main Results:

    • Cadaveric organ transplant outcomes are significantly worse than living donor outcomes.
    • Increased ischemic time directly correlates with higher risks of graft failure and death for heart and lung transplants.
    • Maximum recommended ischemic times: 6 hours for heart, 8 hours for lung.

    Conclusions:

    • Minimizing brain death and ischemia/reperfusion injury is vital for successful organ transplantation.
    • Developing strategies to optimize marginal donor organs is essential due to rising transplantation demands.
    • Effective organ preservation techniques are critical for improving long-term transplant outcomes.